{{Drugbox
| IUPAC_name = (4-methyl-1-naphthalenyl)(2-methyl-1-pentyl-1''H''-indol-3-yl)methanone
| image = JWH-149.png

<!--Clinical data-->
| tradename =  
| legal_CA = Schedule II
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| metabolism =  
| elimination_half-life =  
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 548461-82-1
| PubChem = 45267820
| ChemSpiderID      = 24627235
| UNII = AWD731Y25Z
| UNII_Ref = {{fdacite|correct|FDA}}

<!--Chemical data-->
| C=26 | H=27 | N=1 | O=1
| molecular_weight = 369.50 g/mol
| smiles = c4cccc1c4c(ccc1C)C(=O)c3c2ccccc2n(c3C)CCCCC
| StdInChI          = 1S/C26H27NO/c1-4-5-10-17-27-19(3)25(23-13-8-9-14-24(23)27)26(28)22-16-15-18(2)20-11-6-7-12-21(20)22/h6-9,11-16H,4-5,10,17H2,1-3H3
| StdInChIKey       = JTJAMXUOXJGSCW-UHFFFAOYSA-N
}}

'''JWH-149''' is a synthetic cannabimimetic that was discovered by John W. Huffman. It is the N-pentyl analog of [[JWH-148]]. It is a potent but only moderately selective ligand for the [[Cannabinoid receptor 2|CB<sub>2</sub>]]  receptor, with a binding affinity of ''K''<sub>i</sub> = 0.73 ± 0.03 nM at this subtype, and more than 6 times selectivity over the CB<sub>1</sub> subtype.<ref>{{Cite journal |doi= 10.1016/j.bmc.2004.09.050 |pmid= 15582455 |year= 2005 |last= Huffman |first= J.|title= Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. |volume= 13 |issue= 1 |pages= 89–112 |journal= Bioorganic & Medicinal Chemistry |display-authors=etal}}
</ref>

==See also==

* [[JWH-120]]
* [[JWH-122]]
* [[JWH-148]]
* [[JWH-193]]
* [[JWH-210]]
* [[JWH-398]]

==References==
<references/>

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:JWH cannabinoids]]
[[Category:Naphthoylindoles]]
[[Category:Designer drugs]]


{{cannabinoid-stub}}